We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Advanced Melanoma

Journal Scan / Research · April 26, 2021

Checkpoint Blocker–Induced Autoimmunity, T-Cell Expression Profiles, and Metastatic Melanoma Outcomes

British Journal of Cancer


Additional Info

British Journal of Cancer
Checkpoint Blocker–Induced Autoimmunity is Associated With Favourable Outcome in Metastatic Melanoma and Distinct T-Cell Expression Profiles
Br. J. Cancer 2021 Mar 15;[EPub Ahead of Print], W Ye, A Olsson-Brown, RA Watson, VTF Cheung, RD Morgan, I Nassiri, R Cooper, CA Taylor, U Akbani, O Brain, RN Matin, N Coupe, MR Middleton, M Coles, JJ Sacco, MJ Payne, BP Fairfax

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading